Buscador de publicacions

Publicacions

  • Cereijo R, Taxerås SD, Piquer-Garcia I, Pellitero S, Martínez Franco E, Tarascó J, Moreno P, Balibrea J, Puig-Domingo M, Jiménez-Pavón D, Lerin-Martinez C, Villarroya F and Sánchez-Infantes D.

    Elevated Levels of Circulating miR-92a Are Associated with Impaired Glucose Homeostasis in Patients with Obesity and Correlate with Metabolic Status After Bariatric Surgery.

    OBESITY SURGERY . 30(1): 174-179. Nº de cites: 4

    [doi:10.1007/s11695-019-04104-y]

  • Jimenez-Pavon D, Corral-Perez J, Sánchez-Infantes D, Villarroya F, Ruiz JR and Martinez-Tellez B.

    Infrared Thermography for Estimating Supraclavicular Skin Temperature and BAT Activity in Humans: A Systematic Review.

    Obesity . 27(12): 1932-1949.

    [doi:10.1002/oby.22635]

  • Villarroya J, Cereijo R, Gavalda A, Peyrou M, Giralt M and Villarroya F.

    New insights into the secretory functions of brown adipose tissue.

    J ENDOCRINOL . 243(2): .

    [doi:10.1530/JOE-19-0295]

  • Quesada T, Gavalda A, Moron S, Campderros L, Iglesias R, Giralt M and Villarroya F.

    GPR120 controls neonatal brown adipose tissue thermogenic induction.

    AM J PHYSIOL-ENDOC M . 317(5): . Nº de cites: 4

    [doi:10.1152/ajpendo.00081.2019]

  • Campderros L, Moure R, Cairo M, Gavalda A, Quesada T, Cereijo R, Giralt M, Villarroya J and Villarroya F.

    Brown Adipocytes Secrete GDF15 in Response to Thermogenic Activation.

    Obesity . 27(10): 1606-1616. Nº de cites: 27

    [doi:10.1002/oby.22584]

  • Casasnovas C, Ruiz M, Schlüter A, Naudí A, Fourcade S, Veciana M, Castañer S, Albertí A, Bargalló N, Johnson M, Raymond GV, Fatemi A, Moser AB, Villarroya F, Portero-Otín M, Artuch-Iriberri R, Pamplona R and Pujol A.

    Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study.

    neurotherapeutics : the journal of the american society for experimental neurotherapeutics . 16(4): 1167-1182.

    [doi:10.1007/s13311-019-00735-2]

  • Zarei M, Pujol E, Quesada T, Villarroya F, Barroso E, Vázquez S, Pizarro J, Palomer FX and Vazquez M.

    Oral administration of a new HRI activator as a new strategy to improve high-fat-diet-induced glucose intolerance, hepatic steatosis, and hypertriglyceridaemia through FGF21.

    BRITISH JOURNAL OF PHARMACOLOGY . 176(13): 2292-2305. Nº de cites: 7

    [doi:10.1111/bph.14678]

  • Cairo M, Campderros L, Gavalda A, Cereijo R, Delgado-Anglés A, Quesada T, Giralt M, Villarroya J and Villarroya F.

    Parkin controls brown adipose tissue plasticity in response to adaptive thermogenesis.

    EMBO REP . 20(5): . Nº de cites: 15

    [doi:10.15252/embr.201846832]

  • Ferrer G, Redondo-Angulo I, Guitart-Mampel M, Ruperez C, Mas-Stachurska A, Sitges M, Garrabou G, Villarroya F, Fernández-Solà J and Planavila A.

    Fibroblast growth factor-21 protects against fibrosis in hypertensive heart disease.

    J PATHOL . 248(1): 30-40. Nº de cites: 12

    [doi:10.1002/path.5226]

  • Villarroya J, Cereijo R, Giralt M and Villarroya F.

    Secretory Proteome of Brown Adipocytes in Response to cAMP-Mediated Thermogenic Activation.

    FRONTIERS IN PHYSIOLOGY . 10: 67-67. Nº de cites: 9

    [doi:10.3389/fphys.2019.00067]